Sara Bravaccini

Sara Bravaccini

UNVERIFIED PROFILE

Are you Sara Bravaccini?   Register this Author

Register author
Sara Bravaccini

Sara Bravaccini

Publications by authors named "Sara Bravaccini"

Are you Sara Bravaccini?   Register this Author

58Publications

1187Reads

23Profile Views

Explaining the aggressiveness of breast cancer in sub-Saharan African patients.

J Clin Pathol 2019 10 13;72(10):723-724. Epub 2019 Aug 13.

Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/jclinpath-2019-206071DOI Listing
October 2019

Immunotherapy: The end of the "dark age" for metastatic triple-negative breast cancer?

Breast J 2019 Oct 14. Epub 2019 Oct 14.

Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/tbj.13662DOI Listing
October 2019

What is the best clinical pathological score to identify high-risk patients with lobular carcinoma of the breast who are likely to benefit from adjuvant chemotherapy?

Breast Cancer Res Treat 2019 Aug 22;177(1):231-232. Epub 2019 May 22.

Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, FC, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-019-05275-zDOI Listing
August 2019

What impacts the cost-effectiveness of PD-L1 testing in non-small cell lung cancer?

Authors:
Sara Bravaccini

Lung Cancer 2019 Jun 11;132:152-153. Epub 2019 Mar 11.

Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, FC, Italy. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S01695002193035
Publisher Site
http://dx.doi.org/10.1016/j.lungcan.2019.03.011DOI Listing
June 2019

Analysis of Genetic Alterations in Tunisian Patients with Lung Adenocarcinoma.

Cells 2019 05 28;8(6). Epub 2019 May 28.

Biosciences Laboratory, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola 47014, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3390/cells8060514DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6627075PMC
May 2019

Are Androgen and Estrogen Receptors in DCIS Patients Prognostic Indicators of Relapse Independently of Treatment?

Appl Immunohistochem Mol Morphol 2019 Apr;27(4):301-305

Biosciences Laboratory, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PAI.0000000000000582DOI Listing
April 2019

CD68, CD163, and matrix metalloproteinase 9 (MMP-9) in breast tumor microenvironment to predict breast cancer survival: are they enough?

Breast Cancer Res 2019 04 3;21(1):49. Epub 2019 Apr 3.

Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s13058-019-1134-zDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6448267PMC
April 2019

Androgen receptor in breast cancer: A wolf in sheep's clothing? A lesson from prostate cancer.

Semin Cancer Biol 2019 Apr 16. Epub 2019 Apr 16.

Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.semcancer.2019.04.002DOI Listing
April 2019

Epithelial-to-mesenchymal transition in the context of epidermal growth factor receptor inhibition in non-small-cell lung cancer.

Biol Rev Camb Philos Soc 2018 11 19;93(4):1735-1746. Epub 2018 Apr 19.

Department of Medical Oncology, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Via P. Maroncelli 40, 47014, Meldola, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/brv.12416DOI Listing
November 2018

Are fine-needle aspiration biopsy-derived cell blocks a useful surrogate for tissue samples in breast cancer?

Histopathology 2018 Nov 27;73(5):801-808. Epub 2018 Aug 27.

Biosciences Laboratory, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/his.13694DOI Listing
November 2018

Petals and thorns in programmed death-ligand 1 testing: Is all non-small cell lung cancer diagnostic material suitable?

Cancer Cytopathol 2018 09 21;126(9):817-818. Epub 2018 Sep 21.

Department of Medical Oncology, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncy.22033DOI Listing
September 2018

Clinical utility of fulvestrant in the treatment of breast cancer: a report on the emerging clinical evidence.

Cancer Manag Res 2018 30;10:3083-3099. Epub 2018 Aug 30.

Unit of Biostatistics and Clinical Trials, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2147/CMAR.S137772DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6124791PMC
August 2018

What to look for in cell-free DNA from breast cancer patients.

Breast Cancer Res Treat 2018 Jul 26;170(1):199-200. Epub 2018 Feb 26.

Biosciences Laboratory, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, FC, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-018-4728-8DOI Listing
July 2018

Is Ki67 still a powerful ally in predicting the clinical benefit of anthracyclines  for the adjuvant treatment of early breast cancer?

Breast Cancer Res Treat 2018 Apr 6;168(3):767-768. Epub 2018 Jan 6.

Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Via P. Maroncelli 40, 47014, Meldola (FC), Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-017-4630-9DOI Listing
April 2018

Androgen and oestrogen receptors as potential prognostic markers for patients with ductal carcinoma in situ treated with surgery and radiotherapy.

Int J Exp Pathol 2017 10 28;98(5):289-295. Epub 2017 Nov 28.

Biosciences Laboratory, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/iep.12253DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5743826PMC
October 2017

Setting up a community-based cervical screening service in a low-income country: a pilot study from north-western Tanzania.

Int J Public Health 2017 Sep 19;62(7):755-762. Epub 2017 Apr 19.

Romagna Cancer Registry, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00038-017-0971-8DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5585293PMC
September 2017

Sorafenib for the treatment of breast cancer.

Expert Opin Pharmacother 2017 Apr 7;18(6):621-630. Epub 2017 Apr 7.

a Department of Medical Oncology , Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS , Meldola , Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/14656566.2017.1309024DOI Listing
April 2017

Progress with palbociclib in breast cancer: latest evidence and clinical considerations.

Ther Adv Med Oncol 2017 Feb 21;9(2):83-105. Epub 2016 Nov 21.

Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, FC, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1758834016677961DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5298405PMC
February 2017

Role of Telomerase in Cervical Lesions as Prognostic Marker: A Comparison Between Immunohistochemistry and Fluorescence In Situ Hybridization.

J Low Genit Tract Dis 2017 Jan;21(1):42-46

1Biosciences Laboratory, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola; 2Department of Obstetrics and Gynecology, Morgagni-Pierantoni Hospital, Forlì; and 3Pathology Unit, Santa Maria delle Croci Hospital, Ravenna, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/LGT.0000000000000261DOI Listing
January 2017

Androgen receptor signaling pathways as a target for breast cancer treatment.

Endocr Relat Cancer 2016 10 15;23(10):R485-98. Epub 2016 Aug 15.

Department of Medical OncologyIstituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Forlì-Cesena, Italy

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1530/ERC-16-0190DOI Listing
October 2016

Pharmacokinetics, pharmacodynamics and clinical efficacy of pertuzumab in breast cancer therapy.

Expert Opin Drug Metab Toxicol 2015 26;11(10):1647-63. Epub 2015 Aug 26.

a 1 Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Department of Medical Oncology , Via P. Maroncelli 40, 47014 Meldola (FC), Italy +39 05 4373 9278 ; +39 05 4373 9249 ;

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1517/17425255.2015.1078311DOI Listing
May 2016

Role of androgen and estrogen receptors as prognostic and potential predictive markers of ductal carcinoma in situ of the breast.

Int J Biol Markers 2015 Nov 11;30(4):e425-8. Epub 2015 Nov 11.

Biosciences Laboratory, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola (Forlì-Cesena) - Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5301/jbm.5000163DOI Listing
November 2015

111In-Pentetreotide (OctreoScan) scintigraphy in the staging of small-cell lung cancer: its accuracy and prognostic significance.

Nucl Med Commun 2015 Feb;36(2):135-42

aDepartment of Clinical Oncology, Cervesi Hospital, Cattolica bDepartment of Medical Oncology cRadiology Unit dUnit of Biostatistics and Clinical Trials eBiosciences Laboratory fDiagnostic Nuclear Medicine Unit, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola gNuclear Medicine Unit hPathology Unit, Morgagni-Pierantoni Hospital, Forlì, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MNM.0000000000000221DOI Listing
February 2015

Triple negative breast cancer in a poor resource setting in North-Western Tanzania: a preliminary study of 52 patients.

BMC Res Notes 2014 Jun 26;7:399. Epub 2014 Jun 26.

Pathology Department, Catholic University of Health and Allied Sciences-Bugando, Box 1464, Mwanza, Tanzania.

View Article

Download full-text PDF

Source
http://bmcresnotes.biomedcentral.com/articles/10.1186/1756-0
Publisher Site
http://dx.doi.org/10.1186/1756-0500-7-399DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4081017PMC
June 2014

Palbociclib (PD 0332991) : targeting the cell cycle machinery in breast cancer.

Expert Opin Pharmacother 2014 Feb 26;15(3):407-20. Epub 2013 Dec 26.

Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Department of Medical Oncology , Meldola , Italy +39 0543 739100 ; +39 0543 739151 ;

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1517/14656566.2014.870555DOI Listing
February 2014

Urine cell-free DNA integrity as a marker for early bladder cancer diagnosis: preliminary data.

Urol Oncol 2013 Nov 7;31(8):1744-50. Epub 2012 Nov 7.

Biosciences Laboratory, IRCCS Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST), Meldola, Italy. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.urolonc.2012.07.013DOI Listing
November 2013

Predictive role of telomerase activity in the clinical outcome of patients with benign lesions of the uterine cervix or CIN.

Anal Cell Pathol (Amst) 2012 ;35(5-6):377-80

IRCCS Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST), Meldola, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3233/ACP-2012-0066DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4605540PMC
September 2013

Molecular determinations of EGFR and EML4-ALK on a single slide of NSCLC tissue.

J Clin Pathol 2013 Aug 26;66(8):708-10. Epub 2013 Mar 26.

Biosciences Laboratory, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST-IRCCS), Meldola, FC, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/jclinpath-2013-201502DOI Listing
August 2013

Biofunctional characteristics of in situ and invasive breast carcinoma.

Cell Oncol (Dordr) 2013 Jul 27;36(4):303-10. Epub 2013 Jun 27.

Biosciences Laboratory, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST), IRCCS, Meldola, FC, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s13402-013-0135-7DOI Listing
July 2013

Urinary biomarkers of non-muscle-invasive bladder cancer: current status and future potential.

Expert Rev Anticancer Ther 2012 Jun;12(6):743-52

IRCCS Istituto Scientifico Romagnolo per lo Studio e Cura dei Tumori , Via Piero Maroncelli, 40-47014 Meldola (FC), Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1586/era.12.50DOI Listing
June 2012

Detection of HER2 and Topo 2 in breast cancers: comparison between MLPA and FISH approaches.

J Clin Pathol 2012 Feb 29;65(2):183-5. Epub 2011 Oct 29.

Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (I.R.S.T.), Meldola, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/jclinpath-2011-200342DOI Listing
February 2012

The role of CXCR4 in the prediction of bone metastases from breast cancer: a pilot study.

Oncology 2011 5;80(3-4):225-31. Epub 2011 Jul 5.

Osteoncology Center, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori, Meldola, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000327585DOI Listing
September 2011

Accuracy of urine telomerase activity to detect bladder cancer in symptomatic patients.

Int J Biol Markers 2009 Oct-Dec;24(4):253-7

Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori, Meldola (Forlì-Cesena), Italy.

View Article

Download full-text PDF

Source
March 2010

The current role of telomerase in the diagnosis of bladder cancer.

Indian J Urol 2009 Jan;25(1):40-6

Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (I.R.S.T.), Via Piero Maroncelli 40, 47014 Meldola (FC), Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4103/0970-1591.45535DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2684324PMC
January 2009

Urine telomerase activity for the detection of bladder cancer in females.

J Urol 2007 Jul 11;178(1):57-61. Epub 2007 May 11.

Istituto Oncologico Romagnolo, Morgagni-Pierantoni Hospital, Forlì, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.juro.2007.03.025DOI Listing
July 2007

Usefulness of immunological detection of the human telomerase reverse transcriptase.

Cell Oncol 2005 ;27(5-6):347-53

Division of Oncology, Morgagni-Pierantoni Hospital, Forlì, Italy.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4617503PMC
May 2006